Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Fluarix Tetra 2023 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: influenza quadrivalent vaccine 2023
Brand name
(ARTG)
: FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled PRTC syringe without needleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
FLUARIX TETRA is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types A and B contained in the vaccine (see section 5.1 PHARMACODYNAMIC PROPERTIES, Clinical trials).The use of FLUARIX TETRA should be based on official recommendations.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, suspension
- Intramuscular
- 1.25 ml glass syringes with Luer lock adapter and plastic rigid tip cap (PRTC) with new composition of syringe tip cap
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 15 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 pack
- 10 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
